Dashboard
Manage Tickers

AORTARTIVION, INC.

NYSE artivion.com


$ 25.80 $ 0.20 (0.78 %)    

Wednesday, 03-Jul-2024 12:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 25.85
$ 25.73
$ 0.00 x 0
$ 0.00 x 0
$ 25.35 - $ 25.86
$ 12.16 - $ 26.26
176,758
na
1.24B
$ 1.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 07-30-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-23-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-19-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 03-09-2018 12-31-2017 10-K
27 10-31-2017 09-30-2017 10-Q
28 07-25-2017 06-30-2017 10-Q
29 04-27-2017 03-31-2017 10-Q
30 02-16-2017 12-31-2016 10-K
31 10-27-2016 09-30-2016 10-Q
32 07-26-2016 06-30-2016 10-Q
33 04-29-2016 03-31-2016 10-Q
34 02-16-2016 12-31-2015 10-K
35 10-27-2015 09-30-2015 10-Q
36 07-28-2015 06-30-2015 10-Q
37 04-29-2015 03-31-2015 10-Q
38 02-17-2015 12-31-2014 10-K
39 10-28-2014 09-30-2014 10-Q
40 07-24-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

a-glimpse-into-the-expert-outlook-on-artivion-through-4-analysts
A Glimpse Into The Expert Outlook On Artiv...
07/02/2024 16:01:36

lake-street-maintains-buy-on-artivion-raises-price-target-to-30
Lake Street Maintains Buy on Artivion, Rai...
07/02/2024 14:10:02

Lake Street analyst Frank Takkinen maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $28 to $30.

endospan-announces-agreement-with-artivion-for-additional-loans-up-to-25m-to-support-fda-approval-of-nexus-stent-graft-system
Endospan Announces Agreement With Artivion...
07/02/2024 12:53:39

artivion-amends-agreements-with-endospan-provides-endospan-with-25m-upfront-payment-reduced-to-135m
Artivion Amends Agreements With Endospan; ...
07/01/2024 20:08:53

why-beyond-shares-are-trading-lower-by-over-20-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Beyond Shares Are Trading Lower By Ove...
05/07/2024 18:35:21

tempur-sealy-posts-upbeat-earnings-joins-fibrogen-coca-cola-consolidated-fabrinet-and-other-big-stocks-moving-higher-on-tuesday
Tempur Sealy Posts Upbeat Earnings, Joins ...
05/07/2024 14:53:56

stifel-maintains-buy-on-artivion-raises-price-target-to-25
Stifel Maintains Buy on Artivion, Raises P...
05/07/2024 12:50:14

Stifel analyst Rick Wise maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $22 to $25.

breaking-down-artivion-4-analysts-share-their-views
Breaking Down Artivion: 4 Analysts Share T...
05/07/2024 12:00:26

needham-maintains-buy-on-artivion-raises-price-target-to-30
Needham Maintains Buy on Artivion, Raises ...
05/07/2024 09:55:35

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $25 to $30.

artivion-revises-fy24-revenue-guidance-from-8-12-to-9-12-yy-growth-on-constant-currency-basis
Artivion Revises FY24 Revenue Guidance Fro...
05/06/2024 20:34:46

The Company expects revenues to be in the range of $386 to $396 million compared to the previously articulated range of $382 to...

artivion-q1-2024-adj-eps-006-beats-011-estimate-sales-97431m-beat-91978m-estimate
Artivion Q1 2024 Adj EPS $0.06 Beats $(0.1...
05/06/2024 20:07:19

Artivion (NYSE:AORT) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.11) by 154...

artivion-to-present-new-clinical-data-for-on-x-aortic-heart-valve-and-amds-at-104th-aats-annual-meeting
Artivion To Present New Clinical Data For ...
04/29/2024 12:06:11

5-Year Real-World Safety and Efficacy Data from On-X Aortic Heart Valve Low INR Post-Market Study Demonstrate Even Better Patie...

needham-maintains-buy-on-artivion-maintains-25-price-target
Needham Maintains Buy on Artivion, Maintai...
04/08/2024 18:35:06

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and maintains $25 price target.

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
02/19/2024 13:05:48

why-doordash-shares-are-trading-lower-by-around-12-here-are-other-stocks-moving-in-fridays-mid-day-session
Why DoorDash Shares Are Trading Lower By A...
02/16/2024 18:04:35

Shares of DoorDash, Inc. (NASDAQ: DASH) fell sharply in today’s session as the company reported mixed financial results for it...

applied-materials-posts-upbeat-earnings-joins-texas-roadhouse-vulcan-materials-and-other-big-stocks-moving-higher-on-friday
Applied Materials Posts Upbeat Earnings, J...
02/16/2024 15:09:19

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday.

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/16/2024 13:06:00

needham-maintains-buy-on-artivion-raises-price-target-to-25
Needham Maintains Buy on Artivion, Raises ...
02/16/2024 10:44:29

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $22 to $25.

artivion-sees-fy24-revenue-382m-396m-vs-38426m-est
Artivion Sees FY24 Revenue $382M-$396M Vs ...
02/15/2024 21:07:06

2024 Financial OutlookThe Company expects revenues for the full year 2024 to be in the range of $382 to $396 million, represent...

artivion-q4-eps-011-beats-010-estimate-sales-9367m-beat-8929m-estimate
Artivion Q4 EPS $0.11 Beats $(0.10) Estima...
02/15/2024 21:06:07

Artivion (NYSE:AORT) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.10) by 210...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)